VIVIAN RANDALL W.,YANG ZHENG-YU,LINK JOHN O.,COTTELL JEROMY J.,TAYLOR JAMES,SCHROEDER SCOTT D.,TSE WINSTON C.
申请号：
NZ60052708
公开号：
NZ600527A
申请日:
2008.06.26
申请国别(地区):
NZ
年份:
2014
代理人:
摘要：
600527 Disclosed herein is a compound of formula I, wherein the variables are defined in the specification, and the use thereof of for treating a hepatitis C virus (CV). Additionally disclosed is a pharmaceutical composition comprising said compound, and optionally further comprising at least one additional therapeutic agent such as interferons, ribavirin analogs, NS3 protease inhibitors, NS5b polymerase inhibitors, alpha-glucosidase 1 inhibitors, hepatoprotectants, non-nucleoside inhibitors of HCV, and other drugs for treating HCV.
